1. Home
  2. VYGR vs BSVN Comparison

VYGR vs BSVN Comparison

Compare VYGR & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • BSVN
  • Stock Information
  • Founded
  • VYGR 2013
  • BSVN 2004
  • Country
  • VYGR United States
  • BSVN United States
  • Employees
  • VYGR N/A
  • BSVN N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • BSVN Major Banks
  • Sector
  • VYGR Health Care
  • BSVN Finance
  • Exchange
  • VYGR Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • VYGR 386.1M
  • BSVN 414.8M
  • IPO Year
  • VYGR 2015
  • BSVN 2018
  • Fundamental
  • Price
  • VYGR $5.43
  • BSVN $47.84
  • Analyst Decision
  • VYGR Strong Buy
  • BSVN Buy
  • Analyst Count
  • VYGR 8
  • BSVN 3
  • Target Price
  • VYGR $17.00
  • BSVN $37.00
  • AVG Volume (30 Days)
  • VYGR 583.2K
  • BSVN 29.2K
  • Earning Date
  • VYGR 11-12-2024
  • BSVN 10-11-2024
  • Dividend Yield
  • VYGR N/A
  • BSVN 2.04%
  • EPS Growth
  • VYGR N/A
  • BSVN N/A
  • EPS
  • VYGR 0.47
  • BSVN 3.80
  • Revenue
  • VYGR $163,784,000.00
  • BSVN $85,876,000.00
  • Revenue This Year
  • VYGR N/A
  • BSVN N/A
  • Revenue Next Year
  • VYGR N/A
  • BSVN N/A
  • P/E Ratio
  • VYGR $11.65
  • BSVN $12.36
  • Revenue Growth
  • VYGR 3.40
  • BSVN 10.72
  • 52 Week Low
  • VYGR $5.19
  • BSVN $22.05
  • 52 Week High
  • VYGR $11.72
  • BSVN $49.01
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 34.18
  • BSVN 66.18
  • Support Level
  • VYGR $5.19
  • BSVN $45.77
  • Resistance Level
  • VYGR $5.59
  • BSVN $47.58
  • Average True Range (ATR)
  • VYGR 0.41
  • BSVN 1.44
  • MACD
  • VYGR -0.19
  • BSVN 0.08
  • Stochastic Oscillator
  • VYGR 10.71
  • BSVN 86.04

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a wide variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. it offers commercial real estate lending, hospitality lending, energy lending, and commercial and industrial lending, and also provides consumer lending services to individuals.

Share on Social Networks: